Vittia Annual Report 2022

VITTIA Commercial management GRI 2-6, 2-27,3-3, 206-1, 416-1, 417-1, 417-2 Broad portfolio, diverse solutions, and abundant opportunities As we have a broad portfolio of product lines and offer solutions for all phases of the planting cycle, this profile opens up multiple doors and opportunities for us with customers and the market, in addition to increasing the potential for profitability and cost reduction, as we sell more products and become a preferred supplier to our customer base. We are among the largest domestic manufacturers in the inoculant market and are among the largest players in foliar fertilizers in Brazil. Regardless of this, we have invested a lot and made additional efforts in recent years in the biological products segment, because we believe in the enormous potential of this segment and, also, in line with our direction towards sustainable development. Because we currently have one of the largest portfolios of biological biocontrol and special fertilizers, including biological fertilizers, endorsed for a wide application in the most diverse agricultural crops in Brazil, in addition to a robust portfolio of new products (in different stages of development), we are strategically positioned to meet the growing demand in these markets. These factors, combined with our strategy of continuous proximity to our customers, place us in a strategic position to capture new business opportunities. It is also worth highlighting that we have the necessary technical training to continue innovating and seeking to develop new products and new solutions. We have built a relationship of trust and exchange of knowledge with farmers, bearing in mind that they carefully choose products for crop management. In the case of biological inputs, the agricultural producer tends to apply the products in small areas and gradually increase them. In this way, our sales are both commercial and technical work. GRI 206-1 It is also important to point out that we obey market rules and respect our competitors. In 2022, we had no case of lawsuits for unfair competition, antitrust and monopoly practices. Annual Report 2022 55

View entire presentation